350 related articles for article (PubMed ID: 33588740)
1. Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.
Wakabayashi T; Nakatsuji T; Kambara H; Niinomi I; Oyama S; Inada A; Ueno S; Uchida M; Iwanaga K; Iida T; Hosohata K
Curr Rev Clin Exp Pharmacol; 2022; 17(2):144-148. PubMed ID: 33588740
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
3. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
4. Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews.
Han N; Oh JM; Kim IW
Sci Rep; 2020 Feb; 10(1):3116. PubMed ID: 32080337
[TBL] [Abstract][Full Text] [Related]
5. Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance.
Okada T; Hashiguchi M; Hori S
Int J Clin Pharm; 2022 Dec; 44(6):1332-1341. PubMed ID: 36156764
[TBL] [Abstract][Full Text] [Related]
6. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database.
Niinomi I; Hosohata K; Oyama S; Inada A; Hirai T; Iwanaga K
Int J Clin Pharmacol Ther; 2020 Oct; 58(10):543-549. PubMed ID: 32631486
[TBL] [Abstract][Full Text] [Related]
9. Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
Sato K; Mano T; Iwata A; Toda T
J Alzheimers Dis; 2021; 82(3):1333-1344. PubMed ID: 34151816
[TBL] [Abstract][Full Text] [Related]
10. Current status of adverse event profile of tacrolimus in patients with solid organ transplantation from a pharmacovigilance study.
Kambara H; Oyama S; Inada A; Niinomi I; Wakabayashi T; Hosohata K
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):753-759. PubMed ID: 34402788
[TBL] [Abstract][Full Text] [Related]
11. Neuraminidase inhibitors for preventing and treating influenza in children.
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
[TBL] [Abstract][Full Text] [Related]
12. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
[TBL] [Abstract][Full Text] [Related]
13. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.
Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K; Hosohata K
J Clin Pharm Ther; 2019 Oct; 44(5):775-779. PubMed ID: 31231846
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.
Wakabayashi T; Hosohata K; Oyama S; Inada A; Ueno S; Kambara H; Iida T; Nakatsuji T; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2020; 16():741-747. PubMed ID: 32884275
[TBL] [Abstract][Full Text] [Related]
15. Association between anaphylaxis and anti-influenza drug use: An analysis of the Japanese Adverse Drug Event Report database.
Tanaka H; Ohyama K; Horikomi Y; Ishii T
Drug Discov Ther; 2021; 15(3):150-155. PubMed ID: 34234064
[TBL] [Abstract][Full Text] [Related]
16. Association of moderately abnormal behavior and administered neuraminidase inhibitors.
Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi MY; Okabe N
Drug Discov Ther; 2020 Mar; 14(1):50-53. PubMed ID: 32101820
[TBL] [Abstract][Full Text] [Related]
17. [Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)].
Ono H; Okamura M; Fukushima A
Yakugaku Zasshi; 2018 Sep; 138(9):1201-1215. PubMed ID: 29925727
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database.
Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N
BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369
[TBL] [Abstract][Full Text] [Related]
19. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
[TBL] [Abstract][Full Text] [Related]
20. Association of severe abnormal behavior and acetaminophen with/without neuraminidase inhibitors.
Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
J Infect Chemother; 2019 Jun; 25(6):423-426. PubMed ID: 30744989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
